Ocugen to Participate in Upcoming September Investor and Industry Conferences
Ocugen announced it will present at three upcoming conferences in September 2026, including the Citi 2026 Biopharma Back to School Conference and the H.C. Wainwright 28th Annual Global Investment Conference. The company also plans to present 12-month Phase 2 ArMaDa results for its OCU410 gene therapy for geographic atrophy at the Retina Society 59th Annual Scientific Meeting.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.